SCHEMBL7103827

SCHEMBL7103827

CNN1CC[C@H](c2cccnc2)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 6/20 0.50
▸ CHRNB2 P17787 5/20 0.50
▸ CHRNA4 P43681 4/20 0.50
▸ CHRNA3 P32297 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ CHRNB4 P30926 2/20 0.50
▸ CHRNA2 Q15822 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ HTR3E A5X5Y0 1/20 0.50
▸ PSIP1 O75475 1/20 0.50
▸ TRPA1 O75762 1/20 0.50
▸ HTR3B O95264 1/20 0.50
▸ CHRNA1 P02708 1/20 0.50
▸ CHRNG P07510 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ CHRNB1 P11230 1/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ CHRNA5 P30532 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7097811 1.00 CHRNA7 (0.50) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL7485794 0.91 CYP11B2 (0.55) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL7103330 0.91 CYP11B2 (0.55) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL7489467 0.90 CYP11B2 (0.58) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL7489699 0.90 CYP11B2 (0.58) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL7486085 0.85 CYP11B2 (0.59) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL4827803 0.85 CYP11B2 (0.59) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL13006578 0.80 CYP11B2 (0.54) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL29384803 0.80 CYP11B2 (0.54) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1
SCHEMBL594413 0.80 CYP11B2 (0.54) CHRNA7CHRNB2CHRNA4CHRNA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003500402-A — — 2003-01-07 — — JP claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 — — EP claimed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 — — WO claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 — — EP disclosed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 — — WO disclosed
Send feedback